COPD Trial, Recruiting (NCT02777879)

COPD Trial, Recruiting NCT02777879 Sponsor: NYU Langone Health Condition: COPD

Printed from Voxsanity (voxsanity.com.au) — NCT02777879 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Copd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have smoked more than 20 pack-years (a measure of long-term smoking history) and have a breathing test result showing reduced airflow, but not severely reduced (this is called early-stage COPD, classified as GOLD 1 or 2).
Smokers with normal breathing test results may be eligible to join as a comparison group.

Who may not be able to join:

People whose breathing test shows severely reduced lung function (below a certain threshold — confirm with trial site).
People with significant heart problems, including an abnormal heart electrical test (EKG), known or suspected blocked heart arteries, or heart failure.
People who have diabetes.
People with serious liver or kidney disease.
People with severe blood clotting problems, based on specific blood test results (confirm with trial site).
People who are pregnant.
People who drink more than 6 beers or more than 4 mixed drinks every day.
People who are not able to give informed consent on their own.
People who have taken antibiotics in the past 2 months.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT02777879

Sponsor: NYU Langone Health

Phase: Not Applicable

Status: Recruiting

Condition: COPD

More information: https://clinicaltrials.gov/study/NCT02777879

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have smoked more than 20 pack-years (a measure of long-term smoking history) and have a breathing test result showing reduced airflow, but not severely reduced (this is called early-stage COPD, classified as GOLD 1 or 2).
Smokers with normal breathing test results may be eligible to join as a comparison group.

Who may not be able to join:

People whose breathing test shows severely reduced lung function (below a certain threshold — confirm with trial site).
People with significant heart problems, including an abnormal heart electrical test (EKG), known or suspected blocked heart arteries, or heart failure.
People who have diabetes.
People with serious liver or kidney disease.
People with severe blood clotting problems, based on specific blood test results (confirm with trial site).
People who are pregnant.
People who drink more than 6 beers or more than 4 mixed drinks every day.
People who are not able to give informed consent on their own.
People who have taken antibiotics in the past 2 months.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

NYU Langone Health

Registry

ClinicalTrials.gov

Start date

1 May 2014

Est. completion

1 August 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Site specific microbiome (supraglotic area) constituents using background subtraction and source tracking approaches via a multivariable conditional logistic regression model. following broncho-alveolar lavage, BAL

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov